Kishida Rie, Yin Xin, Abe Sarah Krull, Rahman Md Shafiur, Saito Eiko, Islam Md Rashedul, Lan Qing, Blechter Batel, Rothman Nathaniel, Sawada Norie, Tamakoshi Akiko, Shu Xiao-Ou, Hozawa Atsushi, Kanemura Seiki, Kim Jeongseon, Sugawara Yumi, Park Sue K, Kweon Sun-Seog, Ahsan Habibul, Boffetta Paolo, Chia Kee Seng, Matsuo Keitaro, Qiao You-Lin, Zheng Wei, Inoue Manami, Kang Daehee, Seow Wei Jie
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
Department of Public Health Medicine, Institute of Medicine, and Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan.
Int J Cancer. 2025 Feb 15;156(4):723-733. doi: 10.1002/ijc.35191. Epub 2024 Oct 3.
Family history of lung cancer (FHLC) has been widely studied but most prospective cohort studies have primarily been conducted in non-Asian countries. We assessed the association between FHLC with risk of lung cancer (LC) incidence and mortality in a population of East Asian individuals. A total of 478,354 participants from 11 population-based cohorts in the Asia Cohort Consortium were included. A Cox proportional hazards regression model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). A total of 7,785 LC incident cases were identified. FHLC (any LC subtype) was associated with an increased risk of LC incidence (HR = 1.45, 95% CI = 1.30-1.63). The positive association was observed in men and women (HR = 1.44, 95% CI = 1.26-1.66 in men; HR = 1.47, 95% CI = 1.22-1.79 in women), and in both never-smokers and ever-smokers (HR = 1.43, 95% CI = 1.18-1.73 in never-smokers; HR = 1.46, 95% CI =1.27-1.67 in ever-smokers). FHLC was associated with an increased risk of lung adenocarcinoma (HR = 1.63, 95% CI: 1.36-1. 94), squamous cell carcinoma (HR = 1.88, 95% CI: 1.46-2.44), and other non-small cell LC (HR = 1.94, 95% CI: 1.02-3.68). However, we found no evidence of significant effect modification by sex, smoking status, and ethnic groups. In conclusion, FHLC was associated with increased risk of LC incidence and mortality, and the associations remained consistent regardless of sex, smoking status and ethnic groups among the East Asian population.
肺癌家族史(FHLC)已得到广泛研究,但大多数前瞻性队列研究主要在非亚洲国家进行。我们评估了东亚人群中FHLC与肺癌(LC)发病风险和死亡率之间的关联。亚洲队列联盟中11个基于人群的队列研究共纳入了478354名参与者。采用Cox比例风险回归模型来估计风险比(HR)和95%置信区间(CI)。共识别出7785例LC发病病例。FHLC(任何LC亚型)与LC发病风险增加相关(HR = 1.45,95%CI = 1.30 - 1.63)。在男性和女性中均观察到正相关(男性HR = 1.44,95%CI = 1.26 - 1.66;女性HR = 1.47,95%CI = 1.22 - 1.79),在从不吸烟者和曾经吸烟者中也均如此(从不吸烟者HR = 1.43,95%CI = 1.18 - 1.73;曾经吸烟者HR = 1.46,95%CI = 1.27 - 1.67)。FHLC与肺腺癌风险增加相关(HR = 1.63,95%CI:1.36 - 1.94)、鳞状细胞癌(HR = 1.88,95%CI:1.46 - 2.44)以及其他非小细胞LC(HR = 1.94,95%CI:1.02 - 3.68)。然而,我们未发现性别、吸烟状况和种族对效应有显著修饰作用的证据。总之,FHLC与LC发病风险和死亡率增加相关,并且在东亚人群中,无论性别、吸烟状况和种族如何,这些关联均保持一致。